• 1. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 2. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 3. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 4. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 5. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837

Recent Advances in the Application of 2-Bromo-4-chloro-6-fluorobenzoic Acid (CAS: 1082040-61-6) in Chemical Biology and Pharmaceutical Research

The compound 2-bromo-4-chloro-6-fluorobenzoic acid (CAS: 1082040-61-6) has recently garnered significant attention in chemical biology and pharmaceutical research due to its versatile applications as a key intermediate in the synthesis of bioactive molecules. This halogenated benzoic acid derivative is particularly valued for its ability to serve as a building block in the development of novel drug candidates, especially in the fields of oncology, antimicrobial therapy, and targeted drug delivery systems. Recent studies have highlighted its role in facilitating the introduction of multiple halogen atoms into complex molecular frameworks, thereby enhancing the pharmacological properties of resulting compounds.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the utility of 2-bromo-4-chloro-6-fluorobenzoic acid in the synthesis of potent kinase inhibitors. The research team utilized this compound as a crucial intermediate to develop a series of pyrazole-based derivatives showing remarkable selectivity against specific cancer-related kinases. The presence of multiple halogen atoms in the benzoic acid scaffold was found to significantly improve the binding affinity of these inhibitors to their target proteins, while also enhancing their metabolic stability in vivo.

In the realm of antimicrobial research, a recent breakthrough published in Bioorganic & Medicinal Chemistry Letters (2024) showcased the application of 2-bromo-4-chloro-6-fluorobenzoic acid in the development of novel quinolone antibiotics. The compound served as a key precursor for introducing halogen substituents at strategic positions, resulting in derivatives with improved activity against drug-resistant bacterial strains. Particularly noteworthy was the enhanced penetration of these modified antibiotics through bacterial cell membranes, attributed to the unique electronic properties imparted by the halogen pattern of the benzoic acid intermediate.

From a synthetic chemistry perspective, advances in late-stage functionalization techniques have expanded the utility of 2-bromo-4-chloro-6-fluorobenzoic acid. A 2024 Nature Communications paper detailed a novel palladium-catalyzed cross-coupling strategy that allows for selective modification of each halogen position, enabling the rapid generation of diverse molecular libraries for high-throughput screening. This methodological innovation has significantly accelerated the discovery of lead compounds in several drug development programs.

The pharmaceutical industry has also recognized the growing importance of this compound, with several patent applications filed in 2023-2024 describing its use in proteolysis-targeting chimeras (PROTACs) and other targeted protein degradation technologies. The unique halogen pattern of 2-bromo-4-chloro-6-fluorobenzoic acid has proven particularly valuable in optimizing the linker components of these bifunctional molecules, improving their cellular permeability and target engagement properties.

Looking forward, researchers anticipate expanded applications of 2-bromo-4-chloro-6-fluorobenzoic acid in emerging areas such as covalent drug design and radiopharmaceutical development. The compound's versatility in serving as a platform for further chemical modifications, combined with its favorable physicochemical properties, positions it as a valuable tool in the medicinal chemist's arsenal. Ongoing research efforts are focused on exploring its potential in addressing current challenges in drug discovery, including the development of therapies for previously undruggable targets.

• 2252-37-1(2-Bromo-6-fluorobenzoic acid)
• 1359857-60-5(2-Bromo-6-fluoro-3-methylbenzoic acid)
• 183065-69-2(2,4-Dibromo-6-fluorobenzoic acid)
• 1135531-73-5(2-Bromo-4-chloro-6-fluorobenzaldehyde)
• 1505850-20-3(Methyl 6-bromo-3-chloro-2-fluorobenzoate)
• 743466-98-0(6-Bromo-2-fluoro-3-methylbenzoic acid)
• 1428234-67-6(6-Bromo-3-Chloro-2-Fluorobenzoic Acid)
• 1321613-01-7(4-Bromo-2-chloro-6-fluorobenzoic acid)
• 651026-99-2(2-Bromo-4,6-difluorobenzoic acid)
• 1349708-91-3(4-bromo-5-chloro-2-fluoro-benzoic acid)